Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Universal IP Toolkit (Protein G Agarose Gel): Protocol Guida

    2026-04-10

    Universal IP Toolkit (Protein G Agarose Gel): Technical Workflow Guidance

    What This Product Solves

    Immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) are cornerstone methods for dissecting protein-protein interactions and isolating target proteins from complex mixtures. The Universal IP Toolkit (Protein G Agarose Gel) provides an integrated solution designed to streamline these procedures. By leveraging recombinant Protein G covalently bound to 4% cross-linked agarose beads, the toolkit facilitates reproducible antibody binding and purification workflows. It includes all necessary buffers (lysis, wash, elution, and neutralization) as well as protease inhibitors and sample loading reagents, making it suitable for applications such as Western blot sample preparation and mass spectrometry sample preparation. The product is optimized for mammalian IgGs (including human, mouse, rat, and rabbit) and supports efficient Fc region immunoglobulin binding, enabling robust capture of antibody-protein complexes.

    Protocol Parameters

    • Antibody Binding Capacity | ≥20 mg human IgG per ml gel | Quantitative protein capture from mammalian samples | Ensures efficient immunoprecipitation with sufficient antibody loading; suited for high-yield workflows | product_spec [source]
    • Bead Size | 90 μm (average) | General IP and Co-IP assays | Facilitates rapid sedimentation and uniform handling during wash steps; minimizes loss during transfers | product_spec [source]
    • pH Stability | pH 3–9 | Elution and wash conditions | Allows use of acid elution or neutral buffers without compromising bead integrity or binding capacity | product_spec [source]
    • Sample Storage (Agarose Gel) | 4°C in 20% ethanol | Long-term reagent stability | Maintains bead activity and prevents microbial growth over 12 months | product_spec [source]
    • Protease Inhibitor and Loading Buffer Storage | -20°C | Protease inhibition and sample preservation | Prevents proteolysis and maintains sample integrity during and after IP | product_spec [source]
    • Recommended Elution Approaches | Acid buffer, peptide competition, or SDS-PAGE loading buffer | Downstream analysis by Western blot or MS | Accommodates a range of elution strategies for compatibility with various detection platforms | workflow_recommendation

    Workflow Setup and QC Checklist

    For robust protein-protein interaction study or antibody purification, systematic workflow setup and control are critical. The following checklist aids in maximizing yield and reproducibility:

    • Pre-clear lysates: Remove non-specific binders by incubating lysates with control agarose beads prior to IP.
    • Antibody-bead coupling: Incubate the appropriate amount of antibody (up to the 20 mg/ml gel binding capacity) with the Protein G Agarose Gel for 30–60 min at 4°C with gentle end-over-end mixing.
    • Protease inhibition: Always supplement lysis buffer with the provided EDTA-free protease inhibitor cocktail to preserve protein integrity.
    • Washing: Use the provided 10X TBS (diluted to 1X) for multiple washes, ensuring minimal background and removal of non-specifically bound material.
    • Elution: Select elution method based on downstream application (acidic for native proteins, SDS buffer for denatured analysis, or peptide competition if preserving antibody-antigen interaction is essential).
    • QC step: Run input, flow-through, and eluted fractions on SDS-PAGE to monitor capture and release efficiency.
    • Bead recovery: Allow beads to settle naturally or use gentle centrifugation (workflow recommendation: ≤2,000 x g for 2 min) to avoid bead damage.

    Common Failure Modes and Fixes

    • Poor antibody binding: Confirm species and subclass compatibility with Protein G. For weak-binding antibodies (e.g., some mouse IgG1 or goat IgGs), consider switching to Protein A or alternative beads. [product_spec]
    • High background or non-specific bands: Increase the number of wash steps or use higher stringency buffers (for example, TBS with increased salt concentration). Pre-clearing lysates can also reduce non-specific binding. [workflow_recommendation]
    • Low target protein recovery: Check the efficiency of lysis; optimize lysis buffer and incubation times. Ensure adequate protease inhibitor is present and that samples remain cold throughout. [workflow_recommendation]
    • Bead loss during washes: Use gentle pipetting and allow beads to settle completely before supernatant removal. Avoid excessive centrifugation that may compact or damage beads. [workflow_recommendation]
    • Elution inefficiency: If proteins do not elute with acid or SDS buffer, increase elution time, confirm buffer pH, or consider peptide-based competitive elution. [workflow_recommendation]

    Scope and Limitations

    The Universal IP Toolkit (Protein G Agarose Gel) is optimized for mammalian IgGs, including human IgG1–4, mouse, rat, and rabbit subclasses with strong Protein G affinity. It is not recommended for immunoprecipitation involving antibodies from species or subclasses with limited or no Protein G binding (such as goat IgG or certain mouse IgG1 types). The kit is suitable for applications in protein-protein interaction study, antibody binding and purification, and preparation of samples for Western blotting or mass spectrometry. It does not provide direct compatibility for applications requiring native, unmodified antibody elution unless peptide elution or specific buffer conditions are employed. Downstream applications involving highly sensitive detection (e.g., mass spectrometry) require stringent protease inhibition and thorough washing to avoid contamination. Storage and handling guidelines must be strictly followed to maintain reagent integrity over the recommended 12-month shelf life. All quantitative claims are derived from the product specification or recommended workflow, not peer-reviewed papers.

    Conclusion

    The Universal IP Toolkit (Protein G Agarose Gel) from APExBIO delivers a practical, ready-to-use platform for IP and Co-IP workflows targeting mammalian IgGs. Its robust binding capacity, comprehensive reagent set, and compatibility with common downstream analyses (Western blot, mass spectrometry) make it a reliable choice for protein complex isolation and characterization. Users should validate compatibility with their specific antibody and protein targets and adhere to workflow best practices for optimal results. For further technical specifications and ordering, refer to the product page.